LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression

LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression

Show other versions (1)

Hepatocellular carcinoma (HCC) is a common malignant tumor. LukS-PV is the S component of Panton-Valetine leukocidin (PVL), which is secreted by Staphylococcus aureus. This study investigated the effects of LukS-PV on the proliferation, apoptosis, and cell-cycle progression of HCC cells and the mech...

Full description

Bibliographic Details
Main Authors: Ziran Wang, Wenwei Yu, Yawen Qiang, Liangfei Xu, Fan Ma, Pengsheng Ding, Lan Shi, Wenjiao Chang, Yide Mei, Xiaoling Ma
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Molecular Therapy: Oncolytics
Subjects:
hepatocellular carcinoma
HDAC2
LukS-PV
PTEN
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770520300693

Internet

http://www.sciencedirect.com/science/article/pii/S2372770520300693

Similar Items